[ Edico Genome raises $22M in Series B funding ]

Edico Genome has raised $22 million in Series B funding.

Founded in 2013, Edico Genome develops an automated solution that analyses sequencing data for critically ill newborns, cancer patients, scientists and drug developers.

The new financing will be used to fuel expansion and further development of Edico’s Dragen technology. There’s a lot of additional engineering and software development that needs to be done, and Edico also plans to expand its sales and marketing team.

Funding  Series B
Founded  2013
Country  USA
City  La Jolla, California
Founder / CEO  Pieter van Rooyen
Deal Size  $22M
Investors  Qualcomm Ventures
 Axon Ventures
 Greg Lucier
 Dell Technologies Capital
Previous Investors   Qualcomm Ventures
 EvoNexus